Apollo Endosurgery, Inc.has announced the presentation of results from the Orbera Pivotal Trial at this year�s Digestive Disease Week (DDW)...
The FDA has approved the Orbera Intragastric Balloon, from Apollo Endosurgery, to assist adult patients suffering from obesity – with...
Royal Philips announced the four-year results from the randomized controlled ILLUMENATE Pivotal trial of Stellarex (low-dose Drug-Coated Balloon) in patients...
The FDA has approved a new balloon device to treat obesity without the need for invasive surgery. The ReShape Integrated...
Obalon Therapeutics announced that it has received approval from the FDA of the Obalon Balloon System, a novel, nonsurgical, fully-reversible...
Medtronic announced that new two-year clinical data from the pivotal IN.PACT SFA trial revealed that the IN.PACT Admiral drug-coated balloon...
The prospective, two-year cost-effectiveness study of the IN.PACT Admiral drug eluting balloon (DCB), from Medtronic, carried out in conjunction with...
Boston Scientific announced it has received FDA approval of the Ranger Drug-Coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
The FDA has recently received multiple reports for two different types of adverse events associated with fluid-filled intragastric balloons used...